Randomized Open Label Phase III Trial of Irinotecan Plus Capecitabine versus Capecitabine Monotherapy in Patients with Metastatic Breast Cancer Previously Treated with Anthracycline and Taxane: PROCEED Trial (KCSG BR 11-01)

DOI: 10.4143/crt.2017.562

Keywords: Metastatic breast cancer, Irinotecan, Capecitabine, Clinical trial, Progression free survival

Full-Text   Cite this paper   Add to My Lib

Abstract:

Full-Text